Skip to main content
Erschienen in: Clinical and Translational Oncology 12/2019

29.05.2019 | Correspondence

Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)

verfasst von: F. J. de Haro-del Moral, I. Casans-Tormo, V. Pubul-Nuñez, S. Aguadé-Bruix

Erschienen in: Clinical and Translational Oncology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Excerpt

In attendance to the Editor …
Literatur
1.
Zurück zum Zitat Virizuela JA, García AM, de las Peñas R, Santaballa A, Andrés R, Beato C, et al. SEOM clinical guidelines on cardiovascular toxicity (2018). Clin Transl Oncol. 2019;21:94–105.CrossRef Virizuela JA, García AM, de las Peñas R, Santaballa A, Andrés R, Beato C, et al. SEOM clinical guidelines on cardiovascular toxicity (2018). Clin Transl Oncol. 2019;21:94–105.CrossRef
2.
Zurück zum Zitat López-Fernández T, Thavendiranathan P. Emerging cardiac image modalities for early detection of cardiotoxicity derived for anticancer therapies. Rev Esp Cardiol. 2017;70:487–95.CrossRef López-Fernández T, Thavendiranathan P. Emerging cardiac image modalities for early detection of cardiotoxicity derived for anticancer therapies. Rev Esp Cardiol. 2017;70:487–95.CrossRef
3.
Zurück zum Zitat Zamorano JL, Lancellotti P, Rodríguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC). Eur Heart J. 2016;37(36):2768–801.CrossRef Zamorano JL, Lancellotti P, Rodríguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC). Eur Heart J. 2016;37(36):2768–801.CrossRef
4.
Zurück zum Zitat Alvarez JA, Russell RR. Cardio-oncology: the nuclear option. Curr Cardiol Rep. 2017;19:31.CrossRef Alvarez JA, Russell RR. Cardio-oncology: the nuclear option. Curr Cardiol Rep. 2017;19:31.CrossRef
5.
Zurück zum Zitat Russell RR, Alexander J, Jain D, Poornima IG, Srivastavan AV, Storozynsky E, et al. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. J Nucl Cardiol. 2016;23:856–84.CrossRef Russell RR, Alexander J, Jain D, Poornima IG, Srivastavan AV, Storozynsky E, et al. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. J Nucl Cardiol. 2016;23:856–84.CrossRef
6.
Zurück zum Zitat Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15:1063–93.CrossRef Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15:1063–93.CrossRef
8.
Zurück zum Zitat ICRP. Managing patient dose in computed tomography. ICRP publication 87. Ann ICRP. 2000;30(4):7–45.CrossRef ICRP. Managing patient dose in computed tomography. ICRP publication 87. Ann ICRP. 2000;30(4):7–45.CrossRef
9.
Zurück zum Zitat Gerber TC, Gibbons RJ. Weighing the risks and benefits of cardiac imaging with ionizing radiation. JACC Cardiovasc Imaging. 2010;3:528–35.CrossRef Gerber TC, Gibbons RJ. Weighing the risks and benefits of cardiac imaging with ionizing radiation. JACC Cardiovasc Imaging. 2010;3:528–35.CrossRef
10.
Zurück zum Zitat Thompson RC, Soman P. Striking a balance in the discussion of the benefits of imaging tests and risks of radiation exposure. J Nucl Cardiol. 2019;26:136–7.CrossRef Thompson RC, Soman P. Striking a balance in the discussion of the benefits of imaging tests and risks of radiation exposure. J Nucl Cardiol. 2019;26:136–7.CrossRef
Metadaten
Titel
Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)
verfasst von
F. J. de Haro-del Moral
I. Casans-Tormo
V. Pubul-Nuñez
S. Aguadé-Bruix
Publikationsdatum
29.05.2019
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 12/2019
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-019-02135-6

Weitere Artikel der Ausgabe 12/2019

Clinical and Translational Oncology 12/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.